ENOVIS CORPORATION COMMON STOCK
35.30
02-May-25 16:30:02
15 minutes delayed
Stocks
+0.70
+2.02%
Today's range
34.63 - 35.62
ISIN
N/A
Source
NYSE
-
Enovis Receives FDA Approval of Patient Specific Instrumentation for STAR® Ankle
01 Dec 2022 09:00:01 By Nasdaq GlobeNewswire
-
10 Nov 2022 10:30:00 By Nasdaq GlobeNewswire
-
Enovis Announces Third Quarter 2022 Results
02 Nov 2022 06:00:00 By Nasdaq GlobeNewswire
-
Enovis to Participate in Investor Conferences in November
28 Oct 2022 15:57:58 By Nasdaq GlobeNewswire
-
Enovis to Host Third Quarter 2022 Conference Call on November 2nd
13 Oct 2022 09:30:00 By Nasdaq GlobeNewswire
-
Enovis to Showcase New 510(k) Cleared Foot & Ankle Products at the AOFAS Annual Meeting
08 Sep 2022 09:30:00 By Nasdaq GlobeNewswire
-
Enovis to Participate in Investor Conferences in September
25 Aug 2022 16:01:00 By Nasdaq GlobeNewswire
-
Enovis Announces Second Quarter 2022 Results
04 Aug 2022 06:00:01 By Nasdaq GlobeNewswire
-
Enovis to Host Second Quarter 2022 Conference Call on August 4th
12 Jul 2022 16:01:00 By Nasdaq GlobeNewswire
-
Enovis Completes Acquisition of Insight Medical Systems
06 Jul 2022 08:00:02 By Nasdaq GlobeNewswire
-
Enovis Announces Chief Financial Officer Transition Plan
30 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
Enovis to Participate in the Goldman Sachs Global Healthcare Conference
06 Jun 2022 16:05:00 By Nasdaq GlobeNewswire
-
Enovis Announces First Quarter 2022 Adjusted Stand Alone Results
10 May 2022 07:11:29 By Nasdaq GlobeNewswire
-
Enovis Schedules First Quarter 2022 Earnings Release and Conference Call
14 Apr 2022 13:23:19 By Nasdaq GlobeNewswire